-
BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference | Morningstar
ソース: Buzz FX / 08 11 2024 08:11:28 America/New_York
BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference - BriaCell’s clinical candidates for next generation breast cancer (Bria-BRES+) and prostate cancer (Bria-PROS+
Read more...